39243-70-4

Upstream product

• 67-56-1 methanol 
• 67-66-3 chloroform 

Downstream Products

• 60770-46-9 5-methoxy-2-methyl-benzofuran-3-one 
• 79238-14-5 2,5-dimethoxyphenyl vinyl ketone 
• 89654-20-6 1-(2,5-Dimethoxy-phenyl)-2-methoxy-propan-1-one 
• 101890-84-0 N-[(1RS,2RS)-2-(2,5-dimethoxy-phenyl)-2-hydroxy-1-methyl-ethyl]-phthalimide 
• 111114-04-6 (2,5-Dimethoxyphenyl)-(1-phthalimidoethyl)-keton 

Relevant academic research and scientific papers

Pyrrole derivatives and medicinal composition

The invention relates to a pharmaceutical composition comprising a pyrrole derivative of the following formula [1] or a pharmaceutically acceptable salt thereof, or a solvate of either of them, as an active ingredient. STR1 (wherein R1 represents hydrogen or alkoxycar91 bonylamino, R2 represents alkyl, aryl which may be substituted, aromatic heterocyclyl which may be substituted, unsubstituted amino, monoalkylamino, dialkylamino, or cyclic amino which may be substituted; R3 represents cyano or carbamoyl; R4 represents hydrogen or alkyl; E represents alkylene; q is equal to 0 or 1, A represents methyl, aryl which may be substituted, or aromatic heterocyclyl which may be substituted). The pharmaceutical composition of the invention is effective for the treatment of pollakiuria or urinary incontinence.